Travere Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results

Rhea-AI Summary

Travere Therapeutics (NASDAQ: TVTX) announced it will report its fourth quarter and full year 2022 financial results on February 23, 2023, post-market close. A business update will follow during a webcast at 4:30 p.m. ET on the same day. Investors can access information via the Investor page on Travere's website, and an archived call will be available for 30 days. The company emphasizes its commitment to aiding patients with rare diseases by developing life-changing therapies.

SAN DIEGO, Feb. 16, 2023 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced it will report fourth quarter and full year 2022 financial results on Thursday, February 23, 2023, after the close of the U.S. financial markets. Management will provide an update on the financial results and provide a business update in a webcast on February 23, 2023, at 4:30 p.m. ET.

The webcast and dial-in information can be accessed on the Investor page of Travere’s website at ir.travere.com/events-presentations. Following the live webcast, an archived version of the call will be available for 30 days on the Company’s website.

About Travere Therapeutics

At Travere Therapeutics, we are in rare for life. We are a biopharmaceutical company that comes together every day to help patients, families and caregivers of all backgrounds as they navigate life with a rare disease. On this path, we know the need for treatment options is urgent – that is why our global team works with the rare disease community to identify, develop and deliver life-changing therapies. In pursuit of this mission, we continuously seek to understand the diverse perspectives of rare patients and to courageously forge new paths to make a difference in their lives and provide hope – today and tomorrow. For more information, visit travere.com 

Investor Contact:
Naomi Eichenbaum
888-969-7879
IR@travere.com

FAQ

When will Travere Therapeutics report its financial results for Q4 2022?

Travere Therapeutics will report its Q4 and full year 2022 financial results on February 23, 2023.

What time is the webcast for Travere Therapeutics' financial results?

The webcast for Travere Therapeutics' financial results is scheduled for February 23, 2023, at 4:30 p.m. ET.

Where can I find the webcast for Travere Therapeutics' financial results?

The webcast can be accessed on the Investor page of Travere's website.

Will an archived version of the Travere Therapeutics' financial results call be available?

Yes, an archived version of the call will be available for 30 days on the company's website.